CSL Ltd banner

Economic Moat

CSL has no economic moat

Established rivals can supply competing plasma medicines, while generic alternatives limit protection for parts of CSL’s iron treatment business. CSL’s manufacturing expertise and product approvals create hurdles, but do not by themselves keep capable competitors from pursuing its customers and profits.

Why CSL has no moat

Rivals have substantial scale

Product protection is incomplete

More patients create no lockout

The explanation behind each reason